Live Breaking News & Updates on Public Health Solutions|Page 11

Stay updated with breaking news from Public health solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease In Nonhuman Primate Models Of Ebola And Marburg Viruses

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease In Nonhuman Primate Models Of Ebola And Marburg Viruses
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Hawaii At Manoa , Oreola Donini , Axel Lehrer , Exchange Commission , Johna Burns School Medicine , National Institute Of Allergy , Prnewswire Soligenix Inc , Us Congress , University Of Hawai , Department Of Tropical Medicine , Soligenix Inc , Development Authority , Centers For Disease , Johna Burns School Of Medicine , Company Public Health Solutions , Our Public Health Solutions , Small Business Innovation Research , Us Development , National Institute Of Health , Defense Threat Reduction Agency , Biomedical Advanced Research , Associate Professor , Tropical Medicine , Medical Microbiology , Senior Vice President ,

NYC Synagogue Launches World's First HIV Prevention Training Program For Jewish Clergy

NYC Synagogue Launches World's First HIV Prevention Training Program For Jewish Clergy
tabletmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tabletmag.com Daily Mail and Mail on Sunday newspapers.

Jewish Theological Seminary , New York , United States , David Dunn Bauer , Yeshivat Chovevei Torah , Bronwen Mullin , York City Department Of Health , Faith Based Initiative , Public Health Solutions , York City Council , New York City Based , Congregation Beit , Simchat Torah , New York City , Open Orthodox , Rabbi David Dunn Bauer , West Village , New York City Council , New York City Department , Mental Hygiene ,

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

HyBryte™ has potential to address a critical gap in treatment of early-stage CTCL
PRINCETON, N.J., Dec. 1, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on. ....

Brian Poligone , Richard Straube , Prnewswire Soligenix Inc , Rochester Skin Lymphoma Medical Group , Us Development , National Institute Of Allergy , Defense Threat Reduction Agency , Us Congress , Soligenix Inc , Our Public Health Solutions , European Medicines Agency , Development Authority , Biomedical Advanced Research , Exchange Commission , Senior Vice President , Chief Medical Officer , About Cutaneoust Cell Lymphoma , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,

Soligenix Receives FDA IND Clearance For Phase 2 Clinical Trial Of Dusquetide In The Treatment Of Aphthous Ulcers In Behçet's Disease

Soligenix Receives FDA IND Clearance For Phase 2 Clinical Trial Of Dusquetide In The Treatment Of Aphthous Ulcers In Behçet's Disease
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Robert Hancock , Christopherj Schaber , B Brett Finlay , Prnewswire Soligenix Inc , University Of British Columbia , National Institute Of Allergy , Exchange Commission , Drug Administration , Us Development , Our Public Health Solutions , Defense Threat Reduction Agency , Us Congress , Biomedical Advanced Research , Development Authority , Soligenix Inc , Pipeline Expansion , Novel Innate Defense Regulator Technology , Investigational New Drug , Aphthous Ulcers , Chief Executive Officer , British Columbia , Middle East , East Asia , Public Health Solutions , National Institute ,

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease

Pipeline Expansion of Novel Innate Defense Regulator Technology
PRINCETON, N.J., Nov. 30, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and. ....

United Kingdom , B Brett Finlay , Christopherj Schaber , Robert Hancock , Development Authority , Exchange Commission , Biomedical Advanced Research , Our Public Health Solutions , Us Development , Us Congress , Prnewswire Soligenix Inc , University Of British Columbia , National Institute Of Allergy , Defense Threat Reduction Agency , Soligenix Inc , Drug Administration , Pipeline Expansion , Novel Innate Defense Regulator , Investigational New Drug , Aphthous Ulcers , Chief Executive Officer , British Columbia , Middle East , East Asia , Public Health Solutions , National Institute ,